US Patent 7662925 Optimized Fc variants and methods for their generation

Is a

Patent

Patent attributes

Current Assignee

Xencor

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7662925

Date of Patent

February 16, 2010

Patent Application Number

11483250

Date Filed

July 7, 2006

Patent Citations Received

‌

US Patent 12129303 Anti-interleukin-11 receptor subunit α (IL-11Rα) antibodies

‌

US Patent 12077790 Optimized binuclease fusions and methods

‌

US Patent 12084513 Anti-C1S antibodies and methods of use

‌

US Patent 12129288 Polynucleotides heterodimers of soluble interferon receptors and uses thereof

‌

US Patent 11746150 Anti-LRP5/6 antibodies and methods of use

‌

US Patent 11773171 WNT surrogate molecules and uses thereof

‌

US Patent 11780912 Composition for prophylaxis or treatment of IL-8 related diseases

‌

US Patent 11787871 Methods for the treatment of disease using immunoglobulins having fc regions with altered affinities for FcgammaRactivating and FegammaRinhibiting

...

Patent Primary Examiner

‌

Maher M. Haddad

Patent abstract

The present invention relates to optimized Fc variants, methods for their generation, and antibodies and Fc fusions comprising optimized Fc variants.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 7662925 Optimized Fc variants and methods for their generation

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 7662925 Optimized Fc variants and methods for their generation